Health Care (XLV) Finally Breaks Out To The Bullish Side

healthcare
From Dana Lyons: As other sectors stumble, health care stocks are finally hitting new all-time highs again after two long years.
NYSE:XLV June 21, 2017 6:23am

Pharmaceuticals (PJP) Won’t Be The Only Sector Hurt By Legal Pot

medical-marijuana
From Bill Hall: In my most recent Money and Markets articles, I’ve put you on the inside track about a rapidly growing, yet mostly still under-the-radar, industry. One that the world’s super-rich are quietly funding with their own money, in pursuit of potentially eye-popping investment returns.
NYSE:PJP June 19, 2017 6:12am

How Medical Marijuana Will Disrupt The Pharmaceutical Industry (VHT)

medical-marijuana
From Bill Hall: In my last two Money and Markets articles, I’ve put you on the inside track when I revealed that “family offices” — the preferred investment platforms for many of the world’s mega-millionaires and billionaires — are quietly funding the rapidly growing legal marijuana business.
NYSE:VHT June 10, 2017 7:22am

Building A Truly Diversified Portfolio Is Much Easier Said Than Done

pie-chart
From Steven Vannelli, CFA: There are three basic ways to manage the risk of an equity portfolio, which you'll find below.
NYSE:XLV June 9, 2017 10:55am

What’s Next For Biotech Stocks? (IBB)

biotech-white-pills
From Franklin Templeton Investments: Changing political policies and priorities can impact certain market sectors—for better or worse. Health care costs and prescription drug pricing were hot-button issues in the United States during the 2016 presidential election, and the Trump administration has been pushing forward its own health care agenda.
NASDAQ:IBB June 7, 2017 5:57am

Biotech Firms, NIH Team Up To Stop Trump’s Research Budget Cuts

biotech-medical-pills
The CEOs of several prominent biotech companies joined forces with the head of the National Institutes of Health (NIH) today in Washington to try and convince the White House not to seek major budget reductions for medical research.
NASDAQ:IBB May 8, 2017 4:17pm

Health Care ETFs In Focus As House Votes To Repeal Obamacare

healthcare
From Brad Hoppmann: Republicans in the House of Representatives finally cobbled together enough "yes" votes to do what they’ve been promising to do for some seven years … repeal and replace the "Affordable Care Act" (ACA), aka Obamacare.
NYSE:XLV May 5, 2017 7:14am

BlackRock: Health Care Sector Looks Attractive Amid Global Risks

Medical Device
From BlackRock: With risks abounding in the markets, Russ Koesterich discusses the case for health care as a defensive sector.
NYSE:IYH May 4, 2017 4:13pm

IHI: Keep Riding The Medical Devices Momentum

Medical Device
Momentum traders have no doubt had the healthcare equipment sector on their radar, and maybe even for some time. While the healthcare and biotech sectors were posting losses in 2016, the medical devices sector bucked the trend with the iShares U.S. Medical Devices ETF (IHI) returning more than 9%.
NYSE:IHI April 24, 2017 8:31am

Will Biotech Bulls Or Bears Blink First?

leverage bull bear 600X300
From Taki Tsaklanos: Stock market indexes gain around 1 percent on Thursday. The small cap index Russell 2000 rose around of 1.15%, making it the best performing U.S. stock market index of the day.
NASDAQ:IBB April 21, 2017 6:21am

New Month Brings Fresh Outflows In Small Cap Funds Once Again

smallcap
Analyst Paul Weisbruch of Street One Financial brings us his daily fund flows update, which today picks up on renewed selling of small cap funds, along with some apparent sector rotation into energy and away from a few other sectors.
NYSE:IWM April 5, 2017 12:40pm

BlackRock: Opportunities Abound In Biotech, Healthcare

biotech-white-pills
From BlackRock: A dynamic of haves versus have-nots means that health care is increasingly all about stock picking. Kate Moore sees opportunities in biotech, medical devices, U.S. managed care and selected big pharma with promising drug pipelines.
NASDAQ:IBB April 3, 2017 7:26am

This Tiny Early-Stage Biotech ETF Was Q1’s Best Performing Fund

biotech-dna
From Zacks: After being stressed by the twin attacks of higher drug pricing and increased regulatory scrutiny, the biotech sector has made a strong comeback in the first quarter of 2017.
NASDAQ:BBC March 31, 2017 9:38am

Why You Should Be Avoiding Healthcare Service Stocks Right Now

Medical Device
With a relatively light economic calendar this week, the President’s Obamacare replacement bill (the American Health Care Act if you want to use its formal name, Trumpcare if you don’t) takes center stage as the House is tentatively scheduled to vote on it on Thursday.
NYSE:XHS March 20, 2017 12:55pm

Recommended for You

Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories